Cargando…

In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study

AIMS: Atrial fibrillation (AF) is a risk factor for brain infarction, which can lead to epilepsy. We aimed to investigate whether treatment of AF with direct oral anticoagulants (DOACs) affects the risk of epilepsy in comparison to treatment with the vitamin K antagonist phenprocoumon (PPC). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Platzbecker, Katharina, Müller-Fielitz, Helge, Foraita, Ronja, Koepp, Matthias J, Voss, Annemarie, Pflock, René, Linder, Roland, Pigeot, Iris, Schink, Tania, Schwaninger, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228540/ https://www.ncbi.nlm.nih.gov/pubmed/37013704 http://dx.doi.org/10.1093/europace/euad087

Ejemplares similares

Using Hidden Markov Models to Improve Quantifying Physical Activity in Accelerometer Data – A Simulation Study
por: Witowski, Vitali, et al.
Publicado: (2014)

Primary Prevention from the Epidemiology Perspective: Three Examples from the Practice
por: Pigeot, Iris, et al.
Publicado: (2010)

The influence of aerobic fitness on obesity and its parent-offspring correlations in a cross-sectional study among German families
por: Foraita, Ronja, et al.
Publicado: (2015)

Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany
por: Voss, Annemarie, et al.
Publicado: (2023)

Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance Data
por: Platzbecker, Katharina, et al.
Publicado: (2022)

Incidence and relative risk of hearing disorders in professional musicians
por: Schink, Tania, et al.
Publicado: (2014)

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
por: Komen, Joris J, et al.
Publicado: (2021)

Clone temporal centrality measures for incomplete sequences of graph snapshots
por: Hanke, Moritz, et al.
Publicado: (2017)

Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands
por: Voss, Annemarie, et al.
Publicado: (2023)

Factors influencing sedentary behaviour: A system based analysis using Bayesian networks within DEDIPAC
por: Buck, Christoph, et al.
Publicado: (2019)

Genetic associations vary across the spectrum of fasting serum insulin: results from the European IDEFICS/I.Family children’s cohort
por: Mehlig, Kirsten, et al.
Publicado: (2023)

Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case–Control Study
por: Thöne, Kathrin, et al.
Publicado: (2017)

Polygenic risk for obesity and its interaction with lifestyle and sociodemographic factors in European children and adolescents
por: Hüls, Anke, et al.
Publicado: (2021)

Advances of Molecular Imaging in Epilepsy
por: Galovic, Marian, et al.
Publicado: (2016)

Prospective Analysis of the Association of a Common Variant of FTO (rs9939609) with Adiposity in Children: Results of the IDEFICS Study
por: Lauria, Fabio, et al.
Publicado: (2012)

Treating seizures and epilepsy with anticoagulants?
por: Maggio, Nicola, et al.
Publicado: (2013)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

The Impact of Visualizing Nested Sets. An Empirical Study on Tree Diagrams and Unit Squares
por: Böcherer-Linder, Katharina, et al.
Publicado: (2017)

The incidence of atrial fibrillation, new oral anticoagulation, stroke, and significant bleeds in patients receiving a new dual-chamber pacemaker
por: Parkkari, Elias, et al.
Publicado: (2023)

Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination
por: von Oertzen, Tim J, et al.
Publicado: (2019)

Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany
por: Smits, Elisabeth, et al.
Publicado: (2022)

Absence epilepsy might build its own nest
por: Kozák, Gábor
Publicado: (2019)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter
por: Wall, Christopher, et al.
Publicado: (2019)

The temporal relationship between parental concern of overeating and childhood obesity considering genetic susceptibility: longitudinal results from the IDEFICS/I.Family study
por: Masip, Guiomar, et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Using nirmatrelvir/ritonavir in patients with epilepsy: An update from the Israeli chapter of the International League Against Epilepsy
por: Noyman, Iris, et al.
Publicado: (2022)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Handbook of epidemiology
por: Ahrens, Wolfgang, et al.
Publicado: (2005)

Signal Detection and Monitoring Based on Longitudinal Healthcare Data
por: Suling, Marc, et al.
Publicado: (2012)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dtbsublmsddq59oaheorqm275g